Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 2.057% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) Cc1cc(CCCCCCCCc2cc(C)cc(=O)o2)oc(=O)c1
b.) Cc1ncc(CN2CCCC(C(=O)c3cccc(OC(C)C)c3)C2)s1
c.) CC(Sc1ncn[nH]1)C(=O)Nc1ccc(Cl)cn1
Answer: c. CC(Sc1ncn[nH]1)C(=O)Nc1ccc(Cl)cn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(Sc1ncn[nH]1)C(=O)Nc1ccc(Cl)cn1
CC(Sc1ncn[nH]1)C(=O)Nc1ccc(Cl)cn1
N-(5-chloropyridin-2-yl)-2-(1H-1,2,4-triazol-5-ylsulfanyl)propanamide